In patients with partial response to initial therapy, is there benefit to switching to a new agent for maintenance therapy? Dr. Mark Kris examines studies that address this question. Medscape Hematology-Oncology
Since VZV prophylaxis is effective in bone marrow transplant recipients, should it be considered for other patients with hematologic disorders who are severely myelosuppressed? Clinical Journal of Oncology Nursing
However, subgroup analyses showed a significant effect on overall survival and disease-free survival in women 5 years after menopause. Medscape Medical News
Data are still early, but 2 new blood tests might offer a noninvasive option for detecting gastrointestinal (GI) cancers and for identifying tumors that are likely to metastasize. Medscape Medical News
A meta-analysis has found that platinum-based regimens do not offer significant benefit in survival or overall tumor response, compared with second-line nonplatinum-based regimens. Medscape Medical News
